Oregon House Bill 3267 (Prior Session Legislation)

---

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 2-0)
Status: Failed on June 26 2021 - 100% progression
Action: 2021-06-26 - In committee upon adjournment.
Text: Latest bill text (Introduced) [PDF]

Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Establishes Prescription Drug Affordability Board in Department of Consumer and Business Services to review prices for prescription drug products meeting specified cost criteria. Requires board to establish upper payment limit for drugs that are or are expected to create affordability challenges for health systems and patients in Oregon or health inequities for communities of color. Requires board to establish and assess fees against manufacturers of prescription drug products sold in Oregon for costs of carrying out duties of board. Establishes Prescription Drug Affordability Stakeholder Council to assist board in carrying out its duties.

Relating to the price of prescription drugs.

Rep. Rachel Prusak [D]

Rep. Anna Williams [D]

Date	Chamber	Action
2021-06-26	House	In committee upon adjournment.
2021-02-26	House	Referred to Health Care with subsequent referral to Ways and Means.
2021-02-23	House	First reading. Referred to Speaker's desk.

Type	Source
Summary	https://olis.oregonlegislature.gov/liz/2021R1/Measures/Overview/HB3267
Text	https://olis.oregonlegislature.gov/liz/2021R1/Downloads/MeasureDocument/HB3267/Introduced